Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- estimated blood loss ≥1000 mL within 24 hours of birth (including intrapartum loss)
- uterine atony
- obstetric lacerations and/or expanding hematomas
- signs of hypovolemia
- hypotension
- retained tissue (placenta, membranes, or placenta accreta spectrum)
- uterine defect on bimanual examination
Outros fatores diagnósticos
- symptoms of hypovolemia
- uterine tenderness (secondary PPH)
- signs of infection, e.g., fever (secondary PPH)
Fatores de risco
- placenta previa/low lying placenta
- placenta accreta spectrum
- platelet count <50,000 per microliter
- active antepartum bleeding
- inherited coagulopathy
- acquired coagulopathy
- history of PPH in prior delivery
- operative (assisted) vaginal delivery
- current use of therapeutic anticoagulation
- prior cesarean delivery, uterine surgery, or multiple laparotomies
- uterine overdistension (multiple gestation, polyhydramnios, fetal macrosomia with estimated fetal weight >4000 g)
- grand multiparity (>4 prior births)
- large uterine myomas
- class III obesity (BMI >40)
- pre-existing maternal anemia
- prolonged labor or precipitous delivery
- labor induction or augmentation with prolonged use of oxytocin
- magnesium sulfate use
- cesarean delivery
- placental abruption
- severe preeclampsia or HELLP syndrome
- intrauterine fetal demise (IUFD)
- intrapartum infection
- SSRI or SNRI use in the month before delivery
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- quantification of blood loss
- blood type and crossmatch
Investigações a serem consideradas
- CBC
- uterine ultrasound
- coagulation profile (PT, PTT, INR, fibrinogen)
- inherited coagulation assays
- diagnostic laparotomy
- CT abdomen/pelvis
Novos exames
- thromboelastography (TEG) or rotational thromboelastometry (ROTEM®)
- app-based blood loss quantification technology
Algoritmo de tratamento
primary postpartum hemorrhage: initial presentation
primary postpartum hemorrhage: refractory to initial interventions
secondary postpartum hemorrhage
postpartum hemorrhage resolved
Colaboradores
Autores
Dena Goffman, MD
Vice Chair for Quality and Patient Safety
Department of Obstetrics and Gynecology
Columbia University Irving Medical Center
New York
NY
Divulgaciones
DG declares ongoing advisory board roles for Cooper Surgical Obstetrical Safety Council and Organon Jada Scientific Advisory Board; prior PPH educational speaker roles for PRIME, Haymarket, and Laborie; principal investigator for Treating Abnormal Postpartum Uterine Bleeding or Postpartum Hemorrhage with the Jada System-A Postmarket Registry 6/2021 (grant money paid to institution); NIH grant money paid to institution for Effectiveness of Pictographs to Prevent Wrong-Patient Errors in the NICU, and MPI Simulation for Attending Obstetricians to Improve Technical Skills for Managing Postpartum Hemorrhage; none of the above included an obligation to speak on or disseminate product information.
Lilly Liu, MD, MPH
Department of Obstetrics and Gynecology
Columbia University Irving Medical Center
New York
NY
Divulgaciones
LL declares that she has no competing interests.
Lisa Nathan, MD
Chief of Obstetrics
Department of Obstetrics and Gynecology
Columbia University Irving Medical Center
New York
NY
Divulgaciones
LN has been paid to speak at an Organon symposium on the Jada System for obstetric hemorrhage management.
Revisores por pares
John C. Smulian, MD, MPH
Chair
Department of Obstetrics and Gynecology
University of Florida College of Medicine
Gainesville
FL
Divulgaciones
JCS declares that he has no competing interests.
Dilly O. C. Anumba, MBBS, MD, FRCOG, FWACS, LLM
Professor of Obstetrics and Gynaecology
University of Sheffield
Consultant in Obstetrics and Fetomaternal Medicine
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield
UK
Divulgaciones
DOCA declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-86. Resumen
Main EK, Goffman D, Scavone BM, et al. National partnership for maternal safety: consensus bundle on obstetric hemorrhage. Obstet Gynecol. 2015 Jul;126(1):155-62.Texto completo Resumen
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. 2012 [internet publication].Texto completo Resumen
American College of Obstetricians and Gynecologists. Safe Motherhood Initiative: obstetric hemorrhage bundle [internet publication].Texto completo
Goffman D, Ananth CV, Fleischer A, et al. The New York State Safe Motherhood Initiative: early impact of obstetric hemorrhage bundle implementation. Am J Perinatol. 2019 Nov;36(13):1344-50. Resumen
Bienstock JL, Eke AC, Hueppchen NA. Postpartum hemorrhage. N Engl J Med. 2021 Apr 29;384(17):1635-45.Texto completo Resumen
World Health Organization. WHO recommendations: uterotonics for the prevention of postpartum haemorrhage. 2018 [internet publication].Texto completo Resumen
World Health Organization. WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth. 2020 [internet publication].Texto completo Resumen
World Health Organization. WHO recommendations on the assessment of postpartum blood loss and use of a treatment bundle for postpartum haemorrhage. 2023 [internet publication].Texto completo Resumen
Althabe F, Therrien MNS, Pingray V, et al. Postpartum hemorrhage care bundles to improve adherence to guidelines: a WHO technical consultation. Int J Gynaecol Obstet. 2020 Mar;148(3):290-9.Texto completo Resumen
World Health Organization. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. 2017 [internet publication].Texto completo Resumen
World Health Organization. WHO recommendation on uterine balloon tamponade for the treatment of postpartum haemorrhage. 2021 [internet publication].Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Guías de práctica clínica
- Practice bulletin no. 183: postpartum hemorrhage
- WHO recommendations for the prevention and treatment of postpartum haemorrhage
Más Guías de práctica clínicaVideos
Female urethral catheterization: animated demonstration
Venepuncture and phlebotomy: animated demonstration
Más vídeosInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad